CAS Number: 1025097-10-2
Therapeutic Segment: Anti-infective (gastrointestinal antibacterial agent)
API / Drug Class: Oxazolidinone–fluoroquinolone hybrid antibacterial
Chemical Name: 1-cyclopropyl-6-fluoro-7-[4-[[2-fluoro-4-[(5R)-5-(hydroxymethyl)-2-oxo-1,3-oxazolidin-3-yl]phenoxy]methyl]-4-hydroxypiperidin-1-yl]-4-oxoquinoline-3-carboxylic acid
Molecular Formula: C₂₉H₂₉F₂N₃O₈
Molecular Weight: 585.6 g/mol
Physical Form: Powder
Packaging Type: Double LDPE bags packed in HDPE drums (or equivalent pharma-grade packaging)
Storage Conditions: Store in a cool, dry place; protect from moisture
Specification: As per applicable pharmacopeial or in-house standards
Application Area: Investigational API studied for the treatment of Clostridioides difficile infection
GMP: Y
USFDA: Y
EDQM: Y

▼

Product Description:

Cadazolid is an investigational anti-infective API belonging to the oxazolidinone–fluoroquinolone hybrid antibacterial class. Supplied as a pharmaceutical-grade powder, cadazolid has been studied for its application in the treatment of the Clostridioides difficile infection. The API is handled under controlled conditions to maintain quality and stability, and is packaged in moisture-protective, pharma-grade containers to preserve integrity during transport and storage.

As a leading distribution partner, Molkem Chemicals supports the reliable supply of products aligned with industry quality standards and regulatory expectations. Each product is delivered as per agreed specifications and is supported by standard documentation, including COA, SDS, and TDS. Where required, additional stability data and regulatory assistance can be extended through our technical team.

Related Product

Edoxaban Tosylate

Eberconazole Mononitrate

Ebastine

Doxycycline Monohydrate